2.
The Two-story, 8,000 square-foot facility will allow all outpatient care and services to be under one roof, and will facilitate cooperation among all the professionals responsible for compassionate cancer care and treatment. The Cancer Center provides all state of art diagnostic facilities like X-rays U/Sound CT Scan, MRI open, MRI 1.5T, Pet-CT and a laboratory at ground floor for comfort and calm of all patient to provide best, accurate and early diagnosis. Multidisciplinary cooperation is also essential to our brain cancer research mission, which currently focuses on the continuous periodic follow up of the patients after neurosurgery, radiosurgery, chemotherapy. Neurosurgery scientist-practitioners and their colleagues emphasize basic research that has a great potential for rapid translation into optimal treatment.
The Neurospinal and Cancer care Institute combines multidisciplinary clinical care and a strong research program in an effort to facilitate rapid transfer of basic scientific findings into clinical protocols for patients with tumors of the brain, skull base and spine. The Institute has innovative clinical initiatives organized under the auspices of the Neuro-Oncology Program; the NCCI Pediatric Brain Tumor Program, the NCCI Skull Base Surgery Program, the NCCI Tumor Radiosurgery Program, the NCCI Spinal Tumor Program and the NCCI Neuro-Endocrinology Program.
Diseases treated in the Center include both benign and malignant tumors of the brain, spinal cord, skull base, and spine in adults and children and also whole body cancers. Targeted pathologies include primary parenchymal tumors (including gliomas, craniopharyngiomas, germ cell tumors, and lymphomas), metastatic tumors (including parenchymal, leptomeningeal, and osseous lesions) and tumors of the skull base (including meningiomas, osseous and cartilagenous tumors, pituitary adenomas, acoustic neuromas and glomus tumors).
Minimally invasive therapies, such as microneurosurgery,, stereotactic neurosurgery, endoscopic neurosurgery and radiosurgery are a particular strength. Studies of innovative treatment currently underway include the following:
Radiosurgery of Brain tumors having size less than 30mm, deep seated / inapproachable by surgery, highly vascular, old age patients, or having high morbidity are treated by single session radiosurgery on Gamma knife as day care (one day) treatment.
Other indications of Gamma Knife include arteriovenous malformations, pituitary adenomas, acoustic neurinomas, trigeminal schewanomas, pinealomas, neurofibromas, juglare body tumors, brain stem gliomas, trigeminal neuralgias, germinomas and metastasis.
Fractionated radiosurgery for all the tumors more than 30mm in size including gliomas are treated on X-Knife
Robotic Synergy-S having micro-radiosurgery facilities called IGRT , IGMRT soft wares like Ergo, and VMAT. All tumors of brain; spine and whole body are being treated on X-knife either in single or hypo-fractions 2-5.
This facility is part of Pakistan Gamma knife stereotactic radiosurgery center – a center of excellence for radiosurgery.
Chemotherapy:
- Timozodamide for adult malignat gliomas
- Combination chemotherapy for pediatric tumors
Brain tumors, or neurological complications of other cancers, often have profound implications for patients and their families. Caring for patients with neuro-oncological disease is a complex task that requires input from many specialists.
To meet these challenges, the NCRI, Neuro-Oncology Program has developed an interdisciplinary team whose goals are the following:
- To provide a specific and accurate diagnosis
- To communicate to the patient and the patient's family the nature, treatment options, and possible outcomes of the disease
- To offer both conventional and experimental treatments
- To optimize the quality of each patient's life
- To assist the patient and the patient's family in coping with the disease
